Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.

scientific article published on 7 February 2008

Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1634/STEMCELLS.2007-0562
P698PubMed publication ID18258720
P5875ResearchGate publication ID5592950

P50authorGlenn MarsboomQ41942620
Peter PokreiszQ44814520
Pieter VermeerschQ74614218
Desiré CollenQ127420907
P2093author name stringDésiré Collen
Olivier Gheysens
Stefan Janssens
Hilde Gillijns
Xiaoshun Liu
Marijke Pellens
P2860cites workBone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularizationQ33870103
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathwayQ39946864
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.Q52422731
P433issue4
P921main subjecthypoxiaQ105688
endotheliumQ111140
P304page(s)1017-1026
P577publication date2008-02-07
P1433published inStem CellsQ15724411
P1476titleSustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension
P478volume26

Reverse relations

cites work (P2860)
Q35055700Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells
Q37662882Activation of ATP-sensitive potassium channels facilitates the function of human endothelial colony-forming cells via Ca2+ /Akt/eNOS pathway
Q35607069Acute myocardial rescue with endogenous endothelial progenitor cell therapy
Q33774598Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia
Q53310314Alterations of bone marrow-derived endothelial progenitor cells following acute pulmonary embolism in mice.
Q60935302Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension
Q33806247Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertension
Q42787352Cell-based therapies in pulmonary hypertension: who, what, and when?
Q35929761Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension
Q57470690Dental pulp stem cells overexpressing stromal-derived factor-1α and vascular endothelial growth factor in dental pulp regeneration
Q37070077Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.
Q39093373Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation
Q33839496Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair
Q38072175Endothelial progenitor cell-based therapy for pulmonary arterial hypertension
Q37066764Endothelial progenitor cells in neovascularization of infarcted myocardium
Q37957761Endothelial progenitor cells: current issues on characterization and challenging clinical applications
Q37176444Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
Q41860957Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells
Q33861718Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice
Q46799116Hypoxia-induced proliferation of tissue-resident endothelial progenitor cells in the lung.
Q35321370Isolation and characterization of endothelial progenitor cells from Rhesus monkeys
Q37892336Mechanisms of disease: pulmonary arterial hypertension.
Q33951300Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct
Q38504399Novel Targets of Drug Treatment for Pulmonary Hypertension
Q42267329Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy
Q37907120Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation
Q37789151Prostacyclin therapy for pulmonary arterial hypertension
Q36163044Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension
Q84303950Stem cells and cell therapies in lung biology and lung diseases
Q42850735The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?
Q37570669Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases
Q39772665Treatment of pulmonary arterial hypertension with circulating angiogenic cells
Q54172598[Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].

Search more.